Involvement of annexin V in the antiproliferative effect of GnRH agonist on cultured human uterine leiomyoma cells

Molecular Human Reproduction

Volumn 7, Issue 2, 2001, Pages 169-173

  Yamamoto, H ^a   Sato, H ^a   Shibata, S ^a   Murata, M ^a   Fukuda, J ^a   Tanaka, T ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Annexin V; GnRH agonist; GnRH receptor; Protein kinase C; Uterine leiomyoma

Indexed keywords

BUSERELIN; CALPHOSTIN C; GONADORELIN AGONIST; LIPOCORTIN 5; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE CULTURE; UTERUS MYOMA;

EID: 0035129113     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/7.2.169     Document Type: Article

References (31)

1. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro
2. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
3. A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogue
4. Hormone-induced redistribution of calcium activated phospholipid dependent protein kinase in pituitary gonadotrophs
5. Effects of GnRH on protein kinase C activity of rat granulosa cells
6. Gonadotropin-releasing hormone stimulates phospholipase C but not protein phosphorylation/dephosphorylation in plasma membrane from human epithelial ovarian cancer
7. Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types
8. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium
9. Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta
10. Suppression of calphobindin I (CPBI) production in carcinoma of uterine cervix and endometrium
11. Role of mitogen-activated protein kinase/extracellular signal-related kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line
12. In-vitro model of uterine leiomyomas: Formation of ball-like aggregates
13. Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyomal tissues
14. The role of primer recognition proteins in DNA replication: Inhibition of cellular proliferation by antisense oligodeoxyribonucleotides
15. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin
16. ELISA of calphobindin using monoclonal antibodies
17. Dating the endometrial biopsy
18. Characterization of pituitary calcium activated phospholipid dependent protein kinase; Redistribution by gonadotropin-releasing hormone
19. The concentration of collagen-associated amino acids are higher in GnRH agonists-treated uterine myomas
20. Annexin V inhibits the 12-O-tetradecanoylphrbol-13-acetate-induced activation of Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of Shc in MCF-7 cells
21. Inhibition of protein kinase C by annexin V
22. Calphobindins (placental annexins) inhibit protein kinase C
23. Calphobindin I (annexin V) inhibits protein kinase C
24. Involvement of annexin V in antiproliferative effects of gonadotropin-releasing hormone agonists on human endometrial cancer cell line
25. Investigation of placental anticoagulant protein Calphobindin
26. Insulin-like growth factor I promotes leiomyoma cell growth in vitro
27. Histopathological changes in leiomyomata treated with leuprorelin acetate
28. 2 and phospholipase C
29. Expression of Annexin VI in A431 carcinoma cells suppresses proliferation: A possible role for Annexin VI in cell growth regulation
30. Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells
31. Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata